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Abstract
Background: Multimorbidity is increasingly being recognized as a serious public health concern. Research into its
determinants, prevalence, and management is needed and as the risk of experiencing multiple chronic conditions
increases over time, attention should be given to investigating the development of multimorbidity through
prospective cohort design studies. Here we examine the baseline patterns of multimorbidity and their association
with health outcomes for residents in Yorkshire, England using data from the Yorkshire Health Study.
Methods: Baseline data from the Yorkshire Health Study (YHS) was collected from 27,806 patients recruited
between 2010 and 2012. A two-stage sampling strategy was implemented which first involved recruiting 43
general practice surgeries and then having them consent to mailing invitations to their patients to complete postal
or online questionnaires. The questionnaire collected information on chronic health conditions, demographics,
health-related behaviours, healthcare and medication usage, and a range of other health related variables. Descriptive
statistics (chi-square and t tests) were used to examine associations between these variables and multimorbidity.
Results: In the YHS cohort, 10,332 participants (37.2 %) reported having at least two or more long-term health
conditions (multimorbidity). Older age, BMI and deprivation were all positively associated with multimorbidity. Nearly
half (45.7 %) of participants from the most deprived areas experienced multimorbidity. Based on the weighted sample,
average health-related quality of life decreased with the number of health conditions reported; the mean EQ-5D score
for participants with no conditions was 0.945 compared to 0.355 for participants with five or more. The mean number
of medications used for those without multimorbidity was 1.81 (range 1-13, SD = 1.25) compared to 3.81 (range 1-14,
SD = 2.44) for those with at least two long-term conditions and 7.47 (range 1-37, SD = 7.47) for those with 5+
conditions.
Conclusion: Patterns of multimorbidity within the Yorkshire Health Study support research on multimorbidity
within previous observational cross-sectional studies. The YHS provides both a facility for participant recruitment
to intervention trials, and a large population-based longitudinal cohort for observational research. It is planned
to continue to record chronic conditions and other health related behaviours in future waves which will be
useful for examining determinants and trends in chronic disease and multimorbidity.
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Background
Within the past decade, there has been a growing inter-
est in researching the management, needs, and treat-
ment of those with multiple long term health conditions
[1]. Living with two or more chronic conditions has in-
creasingly become more common as people age, leading
to increased financial pressures on healthcare systems
and treatment burden for those living with multimorbid-
ities. The needs of these patients are complex, with
those experiencing different conditions needing to at-
tend multiple appointments with various doctors, while
managing several medications [2]. This can often lead to
inefficiencies in health care services, with patients at-
tending multiple appointments, and confusion for pa-
tients who may receive conflicting advice from different
specialists involved in their care [2–4]. Multimorbidity
has also been found to be to be associated with increased
healthcare costs, mortality rates, service use, and de-
creased physical functioning and quality of life [2, 3, 5–7],
highlighting the need for more research into the key deter-
minants to detect early signs of risk factors and assess
effective interventions.
Currently, multimorbidity is most commonly defined
as the coexistence of two or more chronic conditions
[5, 8, 9]. These conditions can range across different
long-term, disorders, illnesses, and health problems
[3, 8–10]. Quantifying multimorbidity proves to be
challenging because there has yet to be an inter-
nationally recognised list of conditions defined as
chronic [4]; one recent systematic review of observa-
tional studies on multimorbidity within primary care
found that the number of conditions studied ranged
from five to 335 [11]. While there has been consider-
able discussion around the terms multimorbidity and
comorbidity (the occurrence of medical conditions
additional to an index disease) [9, 12, 13], here we
focus on multimorbidity. This is based on the argu-
ment that multimorbidities may be a better construct
for primary care when the focus is on the individual
as a whole compared to comorbidity which may be
more useful in specialist care where the emphasis is
on an index disease [8].
Most research on multimorbidity is dominated by its
effect on individuals and healthcare services, but the
evidence base for complex interventions within pri-
mary care is very limited and little is known about
patient needs [5, 14]. A recent Cochrane review found
that most studies have focused on multimorbidity in
older patients and evidence for interventions has been
mixed, concluding that further research into particular
risk factors and functional difficulties was needed [10].
There has also been little research into how patients
experiencing multimorbidity view their condition, their
experiences with health services and providers, and how
this relates to the professional construction of multimor-
bidity [5, 8, 11]. Qualitative work among older patients
with diabetes, depression, and osteoarthritis found that
this group wanted convenient access to health care, indivi-
dualised care plans, support from one coordinator of
care, and continuity of relationships with health pro-
fessionals [15], stressing the complex needs of those
with multimorbidities.
Research into multimorbidity is fairly recent, and the
epidemiology of multimorbidity is not well understood,
but is required to help inform decision-making. The aim
of this study was to use baseline data from the Yorkshire
Health Study (YHS) to examine the patterns of multi-
morbidity and their association with health outcomes for
residents in Yorkshire, England.
Methods
Data, recruitment, sampling
The Yorkshire Health Study is a longitudinal panel study
that collects health information on adults aged 16-85. It
was originally designed to address the needs of the
Department of Health Healthy Weight, Healthy Lives re-
port [16], which could not be addressed by existing
population cohorts. The first wave of data was collected
between 2010 and 2012 and surveyed patients residing
in Yorkshire, England. Invitations to complete postal or
online questionnaires were distributed to 156,866 pa-
tients (aged 16-85) recruited from 43 general medical
practices of which 27,806 questionnaires were returned
(15.9 % response rate). The YHS has a small undercount
of younger males and those from deprived areas. Further
details on the data collection methods used and how the
cohort demographic profile compares to the general
Yorkshire population have been published elsewhere
[17, 18] and the second wave of data collection was
completed in January 2016.
A unique design feature of the cohort is that it is the
first cohort study to use the ‘cohort multiple randomised
controlled trial design’ [19], an innovative approach to
tackling some of the problems associated with pragmatic
trial designs (recruitment, ethics, patient preferences and
treatment comparisons). The design enables quick and
easy identification of participants to multiple random-
ized controlled trials within the same population, facili-
tating easier comparability between studies. For each
randomised controlled trial, those eligible are identified
and a random selection offered the trial intervention;
their outcomes are compared with those eligible patients
not offered the intervention.
Measures
One of the original aims for the cohort was to initiate a
programme of research into the management and self-
management of weight and long-term conditions in
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adults living in the South Yorkshire area [18]. Because of
this, a wide range of information was collected allowing
for detailed investigation of variations in obesity in rela-
tion to other dimensions of health, particularly chronic
health conditions. Respondents were able to report on
twelve ‘long standing’ conditions listed in the question-
naire: tiredness/fatigue, pain, insomnia, anxiety/nerves,
depression, diabetes, breathing problems, high blood
pressure, heart disease, osteoarthritis, stroke, and cancer.
An open ended option was also provided which allowed
respondents to report any other conditions not listed.
Demographic information was collected on sex, age,
self-reported height, weight, and waist measurement
(tape measure was provided), ethnicity, highest level of
education, occupation (using 2010 National Statistics
Socioeconomic Classification), and postcode information
was used to measure deprivation via the 2010 Index
of Multiple Deprivation (IMD). The IMD is an area-
based measure for multiple deprivation for small
areas in England [20]. 2010 IMD scores calculated
based on 38 indicators across seven domains (e.g. income,
employment, health, education) range from 0.53 to 87.80
(higher values indicating higher deprivation) and are
assigned to 32,482 areas in England (also known as Lower
layer Super Output Areas). IMD scores were categorised
into quintile groups for our analyses. Health information
related to frequency of health care usage, medication
usage (non-prescription and prescription), and health-
related quality of life using EuroQoL-5D (EQ-5D-3L) were
also collected. The EuroQoL is a standardised instrument
used for measuring five attributes of health status: mobil-
ity, self-care, usual activities, pain/discomfort, and anxiety/
depression [21]. The full original questionnaire and details
about the distributions of these variables have been
published [17, 18].
Analyses
Data was analysed using SPSS Windows v22.0. Descrip-
tive statistics of baseline data are presented in tables,
cross-tabulations, and graphical displays to illustrate
patterns of multimorbidity across demographics, health-
related quality of life, health service, and medication
usage. Multimorbidity was defined as those who self-
reported having at least two of the thirteen long-term
health conditions (i.e. included those responding with an
‘other’ condition) listed in the questionnaire. Bivariate
analyses were conducted to determine associations be-
tween multimorbidity and demographics, deprivation,
EQ-5D scores, health service use and medication usage.
A t-test was used to analyse differences in mean number
of long term health conditions across gender and ethni-
city and one-way ANOVA was used for differences
across age groups, deprivation quintile groups, and body
mass index (BMI) groups. Chi-squared tests were used
to measure differences in the prevalence of multimor-
bidity between all demographic variables (p < 0.05). Sam-
ple weights were applied to data to adjust for groups
who were over-represented in the cohort compared to
the general adult Yorkshire population (females, those
who are older and those living in less deprived areas)
[17, 22]. With the exception of Table 1, data presented
here are based on the weighted sample.
Results
Table 1 presents sample characteristics, mean number of
long standing conditions, and proportions of those with
multimorbidity. Within the unweighted sample, slightly
Table 1 Unweighted sample characteristics and long standing
health conditions for Yorkshire Health Study Wave 1 (N = 27,806)
n (%) Mean number of
conditions (SDa)b
2 or more conditionsc:
n (%)
Gender
Male 12155 (43.7) 1.50 (1.78) 4551 (37.4)
Female 15651 (56.3) 1.49 (1.80) 5781 (36.9)
Age Group
≤24 1734 (6.2) 0.47 (0.92) 188 (10.8)
25-34 2639 (9.5) 0.63 (1.15) 391 (14.8)
35-44 3516 (12.6) 0.83 (1.35) 708 (20.1)
45-54 4489 (16.1) 1.19 (1.62) 1302 (29.0)
55-64 5938 (21.4) 1.63 (1.80) 2412 (40.6)
65-74 5827 (21.0) 2.09 (1.93) 3068 (52.7)
≥75 3254 (11.7) 2.53 (1.93) 2125 (65.3)
Ethnicity
White 26419 (95.0) 1.51 (1.80) 9961 (37.7)
Non-White 1095 (3.9) 1.05 (1.61) 278 (25.4)
Deprivation Quintile
Least Deprived 3948 (14.2) 1.08 (1.46) 1060 (26.8)
Q2 6923 (24.9) 1.30 (1.62) 2275 (32.9)
Q3 4602 (16.6) 1.39 (1.69) 1615 (35.1)
Q4 5116 (18.4) 1.62 (1.85) 2098 (41.0)
Most Deprived 7142 (25.7) 1.88 (2.03) 3263 (45.7)
Body Mass Indexd
Underweight 436 (1.6) 1.29 (1.88) 126 (28.9)
Normal 11101 (39.9) 1.10 (1.51) 3040 (27.4)
Overweight 9671 (34.8) 1.52 (1.74) 3772 (39.0)
Obese 5190 (18.7) 2.26 (2.10) 2833 (54.6)
Missing data not shown in table
a Standard deviation
b Differences between means within ethnicity, age-group, deprivation and BMI
group differed significantly p < 0.001 (t test for independent samples for ethnicity;
one-way ANOVA for age-group, deprivation, and BMI group)
c Differences between categories within age, ethnicity, deprivation, and BMI
group differed significantly p < .0001 (χ2 test for 2 × n tables)
d Calculated by self-reported weight (kg) divided by height-squared (m2).
Categories are based on WHO cut-offs
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over one-third (n = 10,332) had experienced multimor-
bidity (reported having two or more long-standing
conditions). This estimate lowered to 31 % when
based on weighted data (data not shown). The mean
number of self-reported long-term health conditions
varied significantly depending on age, ethnicity, index
of multiple deprivation (IMD) quintile and BMI
group. Multimorbidity was higher among those who
were older, of white ethnicity, resided in more de-
prived areas and were overweight or obese. Overall,
65 % of those aged 75+, 38 % of white participants, and
55 % of obese participants reported having at least two
long-term health conditions. These demographic associa-
tions remained statistically significant when analyses were
conducted on weighted data (results not presented), and
also indicated a significant difference in multimorbidity
between males and females (29 % vs. 32 % respectively).
Within the cohort, there was a clear social gradient be-
tween deprivation and multimorbidity. Nearly half (46 %)
of those living in the most deprived areas experienced
multimorbidity compared to 27 % of those living in the
least deprived areas (Table 1). This link between high
deprivation and multimorbidity was consistent across all
age groups, with prevalence reaching the highest for those
aged over 80 years and living in the most deprived areas
(over 70 %) (Fig. 1).
Of those who reported any long term-conditions
(n = 16,760), 38.4 % (n = 6428) reported experiencing
only one condition. Those who reported a stroke (n
= 400) reported experiencing more multiple long-
term limiting conditions, with 50 % reporting experi-
encing four or more additional chronic conditions
(Fig. 2). Insomnia was the second highest condition
with 46 % of those experiencing this condition along
with at least four others. With the exception of
‘other’ conditions, the condition with the least fre-
quently reported number of conditions alongside it
was breathing problems, 31 % of these participants
only experienced it alone. Figure 3 specifies the pro-
portion of accompanying conditions alongside each
condition. Roughly half of those who had reported
stroke also reported experiencing fatigue, chronic
pain, and high blood pressure. Osteoarthritis and pain
was the most frequent combination of two conditions
(66 % of those with arthritis reported also having
pain), followed by insomnia and fatigue (65 % of
those with insomnia reported fatigue). Fatigue and
pain were commonly reported among other long-term
health conditions (Fig. 3).
Within the cohort there was a negative relationship
between number of self-reported long-term conditions
and self-reported quality of life (Table 2); Participants
with five or more conditions reported a mean EQ-5D
score of 0.355 (range -0.594-1, SE = 0.008), nearly three
times lower than the mean score for participants with
no conditions 0.945 (range -0.594-1, SE = 0.001). Multi-
morbidity was positively associated with more health
service visits (Table 3) and medication use (Fig. 4). Par-
ticipants with no long term health conditions reported
taking on average 1.81 medications (non-prescription
and prescription) compared to those with at least two
long-term conditions who reported 3.8 medications and
those with 5+ conditions who reported 7.5 medications
on average.
0%
10%
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30%
40%
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60%
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80%
90%
100%
Age group
Least Deprived 2 3 4 Most deprived
Fig. 1 Multimorbidity among Yorkshire Health Study participants
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Discussion
Research into multimorbidity has been steadily increas-
ing over the years. Therefore a standard definition of
multimorbidity is required if research in this area is to
advance. The level of prevalence of multimorbidity can
vary across studies depending on the measure used (e.g.
prevalence estimates have ranged from 13 to 95 % across
primary care studies in Europe, North America and
Australia [11]). Conditions within multimorbidity vary
from study to study [5, 11, 23]. For instance, some might
classify depression and anxiety separately while others
could argue that because they are clinically closely inter-
related they should not be treated as separate entities
when classifying those with multimorbidity [6, 8]. In this
study we chose to examine depression and anxiety as
separate entities when estimating multimorbidity as has
been done elsewhere [3]. Based on a simple multimor-
bidity definition (the co-occurrence of two or more con-
ditions whether coincidental or not [12]), overall we
found that 37 % of participants sampled in the Yorkshire
Health Study had experienced multimorbidity. This lies
in between other UK estimates of multimorbidity that
have ranged from 23 % [3] and 30 % in Scotland [24]
to 58 % in England [4]. However it is important to
bear in mind that each study used a different range
of long-term conditions when estimating multimor-
bidity (e.g. learning disability, thyroid disease, epilepsy,
etc.). Within the weighted sample, females were also
more likely to report experiencing multimorbidity,
consistent with other UK, European, and American
studies [1, 11, 25]. Consistent with trends [3], multi-
morbidity steadily increased with age in the YHS
cohort. A clear link between multimorbidity and
deprivation within the YHS cohort was also identified,
supporting evidence found elsewhere which indicate
higher levels of multimorbidity among lower socio-
economic groups [3, 4].
Regarding health outcomes associated with multimor-
bidity, our findings suggest that multimorbidity is associ-
ated with poor health-related quality of life (measured
through EQ-5D scores), which is consistent with find-
ings from previous studies that have used other health-
related quality of life questionnaires (such as the SF-36)
[6]. Patterns of increasing recent hospital, GP, nurse,
dietician, physiotherapist, alternative therapist, and other
carer visits among those with more long-term conditions
were also identified. Health service use in future waves
of the YHS can be compared to multimorbid partici-
pants’ baseline service use and used to prioritize and
adapt the commissioning and management of future
services, particularly by identification of need in different
populations and locations (e.g. areas of high deprivation).
Guidance on the decisions for multiple medication use are
currently lacking within the United Kingdom [26] and
findings from our study suggest that while the proportion
of non-prescription and prescription medications taken is
fairly consistent across the number of conditions reported,
among YHS participants, the number of current medica-
tions increases substantially to an average of 7 medications
for those with five or more self-reported long-term health
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Fig. 2 Distribution of long-standing conditions reported by Yorkshire Health Study participants
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conditions. Furthermore data from our survey supports
the link between obesity and multimorbidity which has
been found elsewhere [27]. Information on a number of
weight management strategies within the YHS [22] could
be used to further explore this link and determine whether
weight loss and strategies used would be associated with a
reduction in the number of chronic conditions over time.
Some limitations of our data should be considered.
Data within the YHS cohort is based on self-report,
which is prone to known biases [28]. However, with re-
gard to multimorbidity, a benefit of using self-report
data is that it includes conditions that patients may not
always report to clinicians or clinicians may under-
record (e.g. anxiety or pain) [3]. Another limitation is
Table 2 EQ-5D by number of long-term conditions
Number of
conditions
Meana Standard error 95 % confidence interval N
0 0.945 0.001 0.943 – 0.947 12978
1 0.859 0.002 0.854 – 0.863 6012
2 0.754 0.004 0.747 – 0.762 3279
3 0.651 0.006 0.640 – 0.662 2083
4 0.532 0.008 0.516 – 0.549 1297
5+ 0.355 0.008 0.339 – 0.371 1677
a Range = 1 (perfect health) through to 0 (dead) to -0.594 (worse than dead) [31]
EQ-5D score not available for all participants
Fig. 3 Self-reported long-term health conditions among Yorkshire Health Study participants
Table 3 Healthcare use in last three months by long-term
conditions (mean number of appointments, standard error)
Number of LTCsa Inpatients Outpatients Day cases A&Eb
0 0.11 (0.010) 0.26 (0.011) 0.07 (0.009) 0.11 (0.005)
1 0.29 (0.041) 0.72 (0.031) 0.16 (0.015) 0.16 (0.009)
2 0.52 (0.063) 1.09 (0.049) 0.33 (0.051) 0.23 (0.015)
3 1.10 (0.218) 1.35 (0.073) 0.44 (0.073) 0.35 (0.034)
4 1.13 (0.190) 1.76 (0.127) 0.49 (0.070) 0.46 (0.053)
5+ 2.05 (0.278) 2.51 (0.138) 1.10 (0.171) 0.59 (0.049)
a LTCs = Long-term conditions
b Accident and Emergency
Li et al. BMC Public Health  (2016) 16:649 Page 6 of 9
that those who responded with an ‘other’ condition
could have also responded with multiple conditions in
the free text response (e.g. arthritis, hypothyroidism,
high cholesterol, epilepsy, glaucoma, irritable bowel syn-
drome, etc.). Within this study we have not analysed
these free text conditions, therefore the number of con-
ditions for this category may be under or over estimated.
Finally, though cross-sectional designs can provide
prevalence estimates and descriptive information that
would allow for identification of potential risk factors,
they do not allow for a deeper understanding of patients’
experiences of living with multimorbidities over the life
course and how these needs and experiences change as
new morbidities are acquired over time. Because of this,
prospective cohort studies have been regarded as the
‘gold standard’ for studying multimorbidity [5]. One re-
cent systematic review of six prospective cohort studies
within primary care found that these studies mainly fo-
cused on only healthcare utilisation, patient’s physical
functioning, and risk factors and concluded that future
cohort studies should also consider examining longitu-
dinal links between socioeconomic factors and mental
illness [5].
The National Institute for Health Care and Excellence
(NICE) is currently consulting on clinical practice guid-
ance for the management of multimorbidity, aiming to
publish guidelines in 2016 [29]. Studies have indicated
that more research should investigate modifiable risk
factors (e.g. smoking and diet), socio-economic dispar-
ities in multimorbidity, and seek to examine multimor-
bidity longitudinally through large-scale prospective
designs [5, 11]. Though not examined in this study, the
second wave of data collection (2013-2015) for the YHS
which was recently completed in January 2016 could
provide further insight into addressing socioeconomic
patterns of multimorbidity over the life course or other
issues e.g. determining the average onset age for multi-
morbidity, identifying risk factors associated with multi-
morbidity over time (via health behaviours collected in
the questionnaire but not examined in this study e.g. al-
cohol consumption, diet, and exercise), or assessing po-
tential complex interventions within primary settings for
patients experiencing multimorbidity and examining the
cost-effectiveness of those interventions (through quality
of life or life satisfaction measures). Because the YHS
was designed to provide a cohort facility for multiple trials
and other studies, its recruitment would allow researchers
to examine specific subgroups (e.g. demographic) or
groups that may be particularly vulnerable to multi-
morbidity (e.g. certain ethnic groups, patients experi-
encing specific conditions). The majority of the cohort
(approximately 78 %) provided consent for researchers to
access their health records [17] which would also enable
data linkage with other disease diagnoses or healthcare
and medication usage reported in other records. An on-
going example is a study that links YHS data with data
from cancer screening programmes to examine the impact
of morbidities (and hence multimorbidity) on the uptake
of colorectal cancer screening [30].
Conclusions
Within our baseline, our findings support evidence
around poor health outcomes for those with multimor-
bidity and indicate a clear socio-economic patterning of
multimorbidity, with those living in the most depriving
areas being more likely to experience multimorbidities.
Overall the YHS is a useful resource for those who are
interested in chronic disease and multimorbidity research
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and would provide researchers with an efficient way of
recruiting patients from a population-based cohort for a
variety of different studies (e.g. randomised control trials,
qualitative, cross-sectional, or longitudinal) alongside a
dataset of rich information on a wide range of relevant
health-related behaviours and conditions for analysing
patterns and trends in chronic disease over time.
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